This market expert warns real estate woes may not be limited to commercial — 3 'idiosyncratic' stocks he likes
Yahoo Finance · 2 days ago
Open | 145.38 |
High | 147.33 |
Low | 144.49 |
Mkt Cap | 13.83B |
P/E (TTM) | 348.45 |
Div & Yield | N/A & N/A |
Prev. Close | 145.61 |
52 Wk. Low | 55.25 |
52 Wk. High | 173.25 |
Related stocks
Biopharmaceutical company
Sarepta Therapeutics, Inc. is a medical research and drug development company with corporate offices and research facilities in Cambridge, Massachusetts, United States. Wikipedia
(USD) | Q1 2024 | Y/Y |
---|---|---|
Revenue | 413.46M | 63.10% ▲ |
Net Income | 36.12M | - |
Diluted EPS | 0.37 | - |
Quarter | EPS Estimate | EPS Actual |
---|---|---|
Q2 2024 | $0.02 | - |
Q1 2024 | -$0.07 | $0.37 |
Q4 2023 | $0.01 | $0.47 |
S&P FuturesES=F | 5,614.75+4.00 (+0.07%) |
Dow FuturesYM=F | 40,713.00+20.00 (+0.05%) |
Nasdaq FuturesNQ=F | 19,997.75-3.25 (-0.02%) |
49.56+2.61% | |
145.180.00% | |
295.45+0.12% |